QuantiGene ViewRNA, developed by Panomics, is a novel mRNA in situ hybridization solution that offers single-copy mRNA sensitivity in single cells in a multiplex assay format. QuantiGene ViewRNA could be purchased from Ramcon in Sweden and Denmark.

• Enables transcriptional profiling of individual cells within a population
• High-throughput applications such as phenotypic or reporter gene screening
• Has broad applicability in research areas including biomarker validation and in vitro and in vivo RNAi delivery and knockdown

QuantiGene product line, developed by Panomics, delivers quantitative gene expression analysis of unparalleled quality and with a much improved work-flow relative to traditional PCR-based methods. QuantiGene product line could be purchased from Ramcon in Sweden and Denmark.

• Quantitative measurement of gene expression directly from Cultured Cells, tissue homogenates, and small amount of peripheral whole blood
• Measuring siRNA-Mediated Knockdown of genes
• Validating Microarray Results

Procarta® Protein Profiling Assays, developed by Panomics, enable simultaneous monitoring of inter- and intracellular protein signaling pathways in a 96-well plate format. Procarta® Protein Profiling Assays could be purchased from Ramcon in Sweden and Denmark.

• Profile human or mouse cytokines in cell culture supernatants, serum or plasma
• Quantify cytokine expression with as little as 25 µL of sample
• Complete assay in 3 hours with a limit of detection of 1 pg/mL/cytokine or less

Panomics is delivering series of products to enable the understanding of a given biology of interest at the cellular level within the context of the cellular environment. Cellular Analysis from Panomics is sold and supported by Ramcon in Sweden and Denmark.

• Versatile, form a single transfection complex and dilute to evaluate multiple peptide concentrations
• High cell viability at optimal delivery conditions
• Screen compounds that inhibit or activate any pathway components